Swisscanto Private Equity

Swisscanto Private Equity is an investment holding company that specializes in asset management services. The firm focuses on investing in growth companies in the late-stage venture and growth capital phases, particularly within the technology and healthtech sectors. Swisscanto Private Equity offers a range of services, including investment management, fund advisory, and private pension solutions, aiming to provide clients with high-quality investment and pension options. The company is dedicated to delivering standard solutions that meet the diverse needs of its customers.

Robert Schier

Investment Director

27 past transactions

ANYbotics

Series B in 2024
ANYbotics AG is a Swiss robotics company founded in 2016 and based in Zurich. The company specializes in developing autonomous legged robots designed for industrial applications, particularly in hazardous and complex environments. These robots feature advanced capabilities such as docking stations, robust waterproof designs, and various sensing technologies. They are equipped to perform tasks like asset monitoring, equipment health checks, and event detection, thereby enhancing productivity and safety for workers in sectors such as oil and gas, power, energy, mining, chemicals, transportation, and construction. With a team of over 100 employees, ANYbotics aims to support industrial facilities in their inspection needs, promoting more sustainable operations through intelligent robotic solutions.

NIL Technology ApS

Venture Round in 2024
NIL Technology ApS specializes in the optical design, prototyping, mastering, and mass production of optical components. The company provides nanostructured masters for various replication technologies, including nanoimprint, UV-replication, hot embossing, roll printing, and injection molding. Its product offerings support a wide range of applications, such as diffractive optics, microlens arrays, metalenses, optical diffusers, beam splitters, waveguides for augmented and mixed reality, wire grid polarizers, structured light systems, and anti-reflection coatings. NIL Technology also develops tailored solutions for industries including biotechnology, space, consumer product packaging, and renewable energy. Established in 2006, the company is headquartered in Kongens Lyngby, Denmark, with an additional branch located in Gothenburg, Sweden.

Fotokite

Series B in 2024
Fotokite specializes in developing autonomous aerial systems designed to assist first responders in emergency situations. Their patented technology integrates with fire trucks and public safety vehicles, allowing firefighters to deploy the system with a single button. Once activated, the Fotokite can ascend to heights of 45 meters, delivering critical real-time information through both thermal and standard video feeds. This capability enhances situational awareness without requiring additional personnel to operate the drone, as it operates autonomously. The tethered system ensures continuous power and data transmission, allowing for extended flight times exceeding 24 hours. The aerial data can be live-streamed to other team members at the scene or back at the station, facilitating better communication and more informed decision-making. By providing immediate and detailed insights upon arrival, Fotokite enhances the ability of first responders to assess incidents and deploy resources effectively.

Memo Therapeutics

Series C in 2023
Memo Therapeutics AG, based in Basel, Switzerland, specializes in innovative antibody discovery and immune repertoire analysis. The company utilizes its proprietary MemoMAB platform, which generates a recombinant in vitro copy of an individual's B cell or antibody repertoire, creating extensive libraries that represent unique immune responses. These libraries are expected to contain a vast array of relevant and rare antibodies, opening new avenues for immune repertoire analysis and antibody discovery. Memo Therapeutics applies this technology in its own antibody lead discovery programs and partners with other entities to enhance research and development in the fields of viral infections and cancer. Through its advancements, Memo Therapeutics aims to significantly improve therapeutic options for patients.

Nagi Bioscience

Series A in 2023
Nagi Bioscience SA, based in Lausanne, Switzerland, specializes in the development and manufacturing of an innovative automated testing device that utilizes microscopic worms for substance testing in pharmaceutical, chemical, and cosmetic industries. Their flagship product, the Caenorhabditis elegans-on-chip, integrates the use of these organisms for in vivo testing with a fully automated platform for in vitro culture, treatment, and analysis. This technology facilitates comprehensive toxicity testing, drug discovery, and anthelmintic testing applications, allowing clients to evaluate biological responses observable only at the whole-organism level. Nagi Bioscience aims to transform traditional testing methodologies by introducing its unique "Organism-on-Chip" technology.

MedTrace Pharma

Venture Round in 2023
MedTrace Pharma A/S, founded in 2015 and headquartered in Kongens Lyngby, Denmark, specializes in medical technology focused on improving positron emission tomography (PET) imaging. The company has developed an automated system, known as MT-100, which facilitates the bedside production and infusion of radioactive water, specifically 15O-water, into patients during PET scans. This innovative approach enhances the sensitivity of imaging results and significantly increases patient throughput. Complementing the MT-100 system is aQuant, an analytical software platform designed to interpret the PET scan data generated from the use of 15O-water. With additional offices in Boston, Massachusetts, and Uppsala, Sweden, MedTrace Pharma aims to advance clinical practices in diagnostic imaging through its cutting-edge technology.

Distran

Series B in 2023
Distran, a spin-off from the Autonomous System Lab at ETH Zurich, specializes in the development of advanced acoustic sensors aimed at enhancing safety for industrial workers and minimizing environmental impact. The company focuses on manufacturing ultrasound cameras that cater to various sectors, including oil and gas, power generation, and chemical engineering. Distran's innovative phased-array sensors address the limitations of traditional acoustic sensors, which often struggle to function effectively in noisy industrial environments. By spatially filtering sounds, these sensors enable the detection of defects such as leaks or discharges from a safe distance, thereby allowing clients to protect their workforce and reduce their ecological footprint.

ANYbotics

Series B in 2023
ANYbotics AG is a Swiss robotics company founded in 2016 and based in Zurich. The company specializes in developing autonomous legged robots designed for industrial applications, particularly in hazardous and complex environments. These robots feature advanced capabilities such as docking stations, robust waterproof designs, and various sensing technologies. They are equipped to perform tasks like asset monitoring, equipment health checks, and event detection, thereby enhancing productivity and safety for workers in sectors such as oil and gas, power, energy, mining, chemicals, transportation, and construction. With a team of over 100 employees, ANYbotics aims to support industrial facilities in their inspection needs, promoting more sustainable operations through intelligent robotic solutions.

EcoRobotix

Series B in 2023
EcoRobotix Ltd is a Swiss company that specializes in the development and manufacture of autonomous farming machines designed for efficient weeding of row crops, meadows, and intercropping cultures. Founded in 2011 and based in Yverdon-les-Bains, the company offers an innovative product known as ARA, which employs advanced AI for plant recognition and ultra-high precision spraying. This technology allows the machine to detect weeds and apply a micro dose of herbicide directly to them, significantly reducing chemical usage by 70-95%. By utilizing a combination of camera systems, GPS RTK, and sensors, EcoRobotix enables farmers to minimize their environmental impact while lowering operational costs and enhancing crop yields.

tado°

Venture Round in 2023
tado° GmbH is a Munich-based company that specializes in developing and marketing home climate control systems. Founded in 2010, the company offers a combination of hardware and software solutions designed to enhance the efficiency of heating and cooling systems in residential and small business environments. tado°'s innovative products adjust to the behavior of residents in real time while also considering weather forecasts and building characteristics. The company distributes its offerings through both retail stores and online platforms, positioning itself at the intersection of technology and sustainable energy management in the cleantech market. With an additional office in London, tado° continues to focus on integrating Internet of Things technology into everyday climate control solutions.

Beekeeper

Series C in 2022
Beekeeper is a mobile communication platform designed specifically for non-desk employees, facilitating real-time messaging and targeted communication across various shifts, locations, and languages. By integrating operational systems and communication channels into a single secure hub, Beekeeper enhances employee engagement and retention while automating processes and minimizing reliance on paper. The platform enables frontline workers to access essential resources such as schedules and paystubs, share files, and assign tasks through group chats or predefined streams. With accessibility from both desktop and mobile devices, Beekeeper empowers organizations to improve productivity and streamline workplace operations effectively.

Memo Therapeutics

Series B in 2022
Memo Therapeutics AG, based in Basel, Switzerland, specializes in innovative antibody discovery and immune repertoire analysis. The company utilizes its proprietary MemoMAB platform, which generates a recombinant in vitro copy of an individual's B cell or antibody repertoire, creating extensive libraries that represent unique immune responses. These libraries are expected to contain a vast array of relevant and rare antibodies, opening new avenues for immune repertoire analysis and antibody discovery. Memo Therapeutics applies this technology in its own antibody lead discovery programs and partners with other entities to enhance research and development in the fields of viral infections and cancer. Through its advancements, Memo Therapeutics aims to significantly improve therapeutic options for patients.

Fotokite

Series B in 2022
Fotokite specializes in developing autonomous aerial systems designed to assist first responders in emergency situations. Their patented technology integrates with fire trucks and public safety vehicles, allowing firefighters to deploy the system with a single button. Once activated, the Fotokite can ascend to heights of 45 meters, delivering critical real-time information through both thermal and standard video feeds. This capability enhances situational awareness without requiring additional personnel to operate the drone, as it operates autonomously. The tethered system ensures continuous power and data transmission, allowing for extended flight times exceeding 24 hours. The aerial data can be live-streamed to other team members at the scene or back at the station, facilitating better communication and more informed decision-making. By providing immediate and detailed insights upon arrival, Fotokite enhances the ability of first responders to assess incidents and deploy resources effectively.

Medimaps Group

Venture Round in 2021
Medimaps Group specializes in developing medical tools that enhance the assessment of bone microarchitecture, particularly for diagnosing and managing osteoporosis. The company's software utilizes artificial intelligence to analyze imaging data from various sources, including DXA, X-ray, and projected CT images, employing techniques such as the trabecular bone score. By providing detailed insights into bone texture, Medimaps Group aids physicians in selecting appropriate treatment options and monitoring patient outcomes. Additionally, the company is exploring future applications of its technology in the dental and orthopedic fields, further expanding its impact on patient care through improved assessment of bone health.

Beekeeper

Convertible Note in 2021
Beekeeper is a mobile communication platform designed specifically for non-desk employees, facilitating real-time messaging and targeted communication across various shifts, locations, and languages. By integrating operational systems and communication channels into a single secure hub, Beekeeper enhances employee engagement and retention while automating processes and minimizing reliance on paper. The platform enables frontline workers to access essential resources such as schedules and paystubs, share files, and assign tasks through group chats or predefined streams. With accessibility from both desktop and mobile devices, Beekeeper empowers organizations to improve productivity and streamline workplace operations effectively.

Sulzer Schmid

Series B in 2021
Sulzer Schmid is an independent Swiss technology company specializing in advanced solutions for the inspection and analysis of rotor blades. The company has developed a cloud-based platform that provides comprehensive inspection tools and data analytics. This platform offers a transparent view of the health status of rotor blades, enabling windmill operators to capture visual data, process images, and generate customizable reports. By tracking damage progression over time, Sulzer Schmid helps customers make informed decisions regarding repairs and maintenance, ultimately enhancing the efficiency and safety of wind energy operations.

MedTrace Pharma

Venture Round in 2021
MedTrace Pharma A/S, founded in 2015 and headquartered in Kongens Lyngby, Denmark, specializes in medical technology focused on improving positron emission tomography (PET) imaging. The company has developed an automated system, known as MT-100, which facilitates the bedside production and infusion of radioactive water, specifically 15O-water, into patients during PET scans. This innovative approach enhances the sensitivity of imaging results and significantly increases patient throughput. Complementing the MT-100 system is aQuant, an analytical software platform designed to interpret the PET scan data generated from the use of 15O-water. With additional offices in Boston, Massachusetts, and Uppsala, Sweden, MedTrace Pharma aims to advance clinical practices in diagnostic imaging through its cutting-edge technology.
At 1plusX, we empower publishers and advertisers to take control of their first-party assets to drive business results. Our real-time data management, data clean room, and CTV solutions converge to help customers engage their audiences with more meaningful and personalized content and advertising. We support publishers in monetizing their inventory and optimize advertisers’ marketing performance through data. So far, we’ve enhanced the marketing performance of companies around the world including Axel Springer, BI Garage, Le Figaro, South China Morning Post, and Tegna. And now part of TripleLift as of March 2022, the advertising technology company reinventing ad placement at the intersection of creative, media and data, we’re bringing publishers and marketers the most viable solution for the privacy-centric era of advertising.

Memo Therapeutics

Series B in 2020
Memo Therapeutics AG, based in Basel, Switzerland, specializes in innovative antibody discovery and immune repertoire analysis. The company utilizes its proprietary MemoMAB platform, which generates a recombinant in vitro copy of an individual's B cell or antibody repertoire, creating extensive libraries that represent unique immune responses. These libraries are expected to contain a vast array of relevant and rare antibodies, opening new avenues for immune repertoire analysis and antibody discovery. Memo Therapeutics applies this technology in its own antibody lead discovery programs and partners with other entities to enhance research and development in the fields of viral infections and cancer. Through its advancements, Memo Therapeutics aims to significantly improve therapeutic options for patients.

Varjo

Series C in 2020
Varjo specializes in developing advanced virtual reality (VR) and extended reality (XR) headsets that offer photorealistic visual fidelity and immersive experiences. Their innovative bionic display technology allows users to see virtual and augmented content with clarity comparable to the real world. Varjo's headsets feature low latency, high-definition stereo, and integrated eye tracking, enhancing the realism of virtual environments. The company serves a range of high-profile clients, including automotive and aerospace leaders, and aims to transform the way individuals work, learn, and interact in a future metaverse. Through its technology, Varjo is committed to elevating performance and emotional engagement in both professional and recreational settings.

Beekeeper

Series B in 2020
Beekeeper is a mobile communication platform designed specifically for non-desk employees, facilitating real-time messaging and targeted communication across various shifts, locations, and languages. By integrating operational systems and communication channels into a single secure hub, Beekeeper enhances employee engagement and retention while automating processes and minimizing reliance on paper. The platform enables frontline workers to access essential resources such as schedules and paystubs, share files, and assign tasks through group chats or predefined streams. With accessibility from both desktop and mobile devices, Beekeeper empowers organizations to improve productivity and streamline workplace operations effectively.

Versantis

Series B in 2019
Versantis AG is a Swiss pharmaceutical company focused on developing innovative medicines and diagnostics for liver diseases. Founded in 2015 and based in Zurich, the company is dedicated to addressing the unmet medical needs of patients globally. Its lead candidate, VS-01, is in the preclinical stage and aims to be the first drug for acute liver disease, with the unique capability of supporting multiple organ function. VS-01 has received Orphan Drug Designation for acute liver failure, highlighting its potential in treating rare conditions. Additionally, Versantis is advancing other products in its pipeline, including VS-02 and VS-03, which target chronic liver diseases and drug intoxications, respectively. These developments represent significant opportunities for improving patient outcomes in the field of liver health and beyond.

Beekeeper

Series B in 2019
Beekeeper is a mobile communication platform designed specifically for non-desk employees, facilitating real-time messaging and targeted communication across various shifts, locations, and languages. By integrating operational systems and communication channels into a single secure hub, Beekeeper enhances employee engagement and retention while automating processes and minimizing reliance on paper. The platform enables frontline workers to access essential resources such as schedules and paystubs, share files, and assign tasks through group chats or predefined streams. With accessibility from both desktop and mobile devices, Beekeeper empowers organizations to improve productivity and streamline workplace operations effectively.

SWISSto12

Series B in 2019
SWISSto12 SA is a manufacturer of radio frequency (RF) and microwave components and systems, specializing in the production of various antenna types, including horn antennas, airborne Ku and Ka band antenna arrays, and slotted waveguide antennas. The company also offers polymer and metal waveguide products, along with a range of filter products, including diplexers and custom filters. Founded in 2011 as a spin-off from the Swiss Federal Institute of Technology in Lausanne, SWISSto12 utilizes innovative 3D printing techniques to create metal-coated components for (sub)mm-wave signal transmission, enhancing design flexibility while reducing costs and lead times. In addition to its manufacturing capabilities, the company provides integration and testing services, as well as a software solution for material properties extraction. SWISSto12 serves various sectors, including satellite communications, airborne satellites, and research centers, and has operations in Renens, Switzerland, as well as offices in Santa Clara, California, and Rehovot, Israel.

GetYourGuide

Series E in 2019
GetYourGuide operates an online platform that allows users to book tours, attractions, and activities globally. Founded in June 2009 by Jochen Mattes, Johannes Reck, Martin Sieber, Pascal Mathis, Tao Tao, and Tobias Rein, the company acts as a mediator between customers and service providers, facilitating the booking of experiences such as cooking classes and skip-the-line tickets for popular tourist sites. The platform is accessible via the internet and mobile applications, providing a variety of options for travelers, including last-minute activities and guided tours. While the service is free for customers, providers pay GetYourGuide a percentage of their revenue for each booking. An integrated customer review system helps users assess the quality of tour providers, with the platform actively removing those that consistently receive poor reviews.

GetYourGuide

Secondary Market in 2019
GetYourGuide operates an online platform that allows users to book tours, attractions, and activities globally. Founded in June 2009 by Jochen Mattes, Johannes Reck, Martin Sieber, Pascal Mathis, Tao Tao, and Tobias Rein, the company acts as a mediator between customers and service providers, facilitating the booking of experiences such as cooking classes and skip-the-line tickets for popular tourist sites. The platform is accessible via the internet and mobile applications, providing a variety of options for travelers, including last-minute activities and guided tours. While the service is free for customers, providers pay GetYourGuide a percentage of their revenue for each booking. An integrated customer review system helps users assess the quality of tour providers, with the platform actively removing those that consistently receive poor reviews.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.